• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Roche dis­con­tin­ues low dose in Hunt­ing­ton’s tri­al, will switch pa­tients to high dose

Last month
R&D

US drugs re­ly heav­i­ly on in­gre­di­ents made over­seas, new re­port shows

Last month
Pharma
Manufacturing

What it took for Wal­greens to go pri­vate

Last month
Health Tech

Sanofi to pay $125M up­front for two im­munol­o­gy drugs from lit­tle-known biotech

Last month
Deals

Bay­er opens $44M US ex­pan­sion; Meri­bel CD­MO launch­es in Eu­rope

Last month
Manufacturing

Unit­ed­Health re­ports 'unusu­al and un­ac­cept­able' earn­ings as Medicare costs climb

Last month
Health Tech

Nether­lands pours $1.5B in­to biotech in pur­suit of glob­al lead­er­ship am­bi­tions

Last month
Financing
R&D

Sarep­ta los­es CMO to RNA edit­ing up­start; An­oth­er wave of per­son­nel moves at Dyne

Last month
Peer Review

Ex­clu­sive: BigHat inks Lil­ly deal for AI-boost­ed an­ti­bod­ies, ex­tends Se­ries B

Last month
Financing
AI

Eli Lil­ly re­ports first Phase 3 da­ta for oral GLP-1, post­ing a win in di­a­betes

Last month
R&D

Ex­clu­sive: Charm Ther­a­peu­tic­s' founder steps down as CEO, as AI biotech eyes clin­ic in 2026

Last month
People
AI

CDC ad­vi­sors broad­en RSV vac­cine rec­om­men­da­tions to at-risk adults in their 50s

Last month
R&D

Phar­ma's wins and loss­es in Trump's sprawl­ing ex­ec­u­tive or­der on drug prices

Last month
Pharma
FDA+

No­var­tis ter­mi­nates knee pain study; Telix re­ports brain tu­mor da­ta

Last month
News Briefing

Biotech seed rounds sink to low­est lev­el in years as in­dus­try slump drags on

Last month
Financing
Startups

Ayr­mid miss­es dead­line for de­tailed of­fer to top pri­vate eq­ui­ty bid for blue­bird

Last month
Deals
Cell/Gene Tx

Biotechs start to dis­close tar­iff ex­po­sure with US trade in­quiry un­der­way 

Last month
Pharma
Manufacturing

Gly­comine rais­es $115M to see if it can treat rare gly­co­sy­la­tion dis­or­der

Last month
Financing
Startups

GeneDx to buy Fab­ric Ge­nomics for up to $51M

Last month
Deals
Diagnostics

At ACIP hear­ing, CDC says it's 'scrap­ing' to re­spond to measles out­break; FDA com­ments on No­vavax halt

Last month
Pharma
FDA+

Trump pledges his sup­port for a change to the IRA long sought by drug­mak­ers

Last month
Pharma
Law

Click gets FDA au­tho­riza­tion for pre­ven­tive mi­graine dig­i­tal ther­a­peu­tic

Last month
FDA+
Health Tech

Leqem­bi wins EU au­tho­riza­tion for some Alzheimer's pa­tients, giv­ing Bio­gen, Ei­sai a boost over Lil­ly

Last month
Pharma
FDA+

J&J's Du­a­to says 'not tar­iffs, but tax pol­i­cy' is best way to boost US man­u­fac­tur­ing

Last month
Pharma
Manufacturing
First page Previous page 14151617181920 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Confirm Profile

Endpoints News